BioStock: Dr. Hoffmann presented Chordate Medical’s results in the US

Chordate Medical’s PM007 clinical trial show that treatment with Kinetic Oscillation Stimulation is an effective and safe option for the preventative treatment of chronic migraine. Dr. Jan Hoffmann, principal investigator in the study, recently presented the primary outcomes at the American Headache Society Scientific Meeting. In addition, a case study has been presented at a congress in Berlin showing encouraging treatment results for a 45-year-old woman from the PM007 study. BioStock talked to Dr. Hoffmann about his experience from the study and the K.O.S treatment.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/07/dr-hoffmann-presented-chordate-medicals-results-in-the-us/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se